A Multicentre Randomised Placebo-Controlled Double-Blind Clinical Trial for Evaluation of Safety and Efficacy of Immunotherapy With an Aluminium Hydroxide-Adsorbed Cocktail of Recombinant Derivatives of Major Allergens of Timothy Grass (Phleum Pratense).
Phase of Trial: Phase III
Latest Information Update: 18 Jan 2013
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Grass pollen hypersensitivity; Rhinoconjunctivitis
- Focus Registrational; Therapeutic Use
- 21 Nov 2006 New trial record.